Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses.

Birrell MA, Catley MC, Hardaker E, Wong S, Willson TM, McCluskie K, Leonard T, Farrow SN, Collins JL, Haj-Yahia S, Belvisi MG.

J Biol Chem. 2007 Nov 2;282(44):31882-90. Epub 2007 Aug 31.

2.

Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.

Smoak K, Madenspacher J, Jeyaseelan S, Williams B, Dixon D, Poch KR, Nick JA, Worthen GS, Fessler MB.

J Immunol. 2008 Mar 1;180(5):3305-12.

3.

Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.

Ogawa D, Stone JF, Takata Y, Blaschke F, Chu VH, Towler DA, Law RE, Hsueh WA, Bruemmer D.

Circ Res. 2005 Apr 15;96(7):e59-67. Epub 2005 Mar 24.

PMID:
15790955
4.

A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.

Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK.

Circ Res. 2006 Dec 8;99(12):e88-99. Epub 2006 Nov 16.

PMID:
17110595
5.

Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages.

Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, Chinetti-Gbaguidi G.

Circ Res. 2007 Jul 6;101(1):40-9. Epub 2007 May 31.

PMID:
17540978
6.

Liver X receptor agonists increase airway reactivity in a model of asthma via increasing airway smooth muscle growth.

Birrell MA, De Alba J, Catley MC, Hardaker E, Wong S, Collins M, Clarke DL, Farrow SN, Willson TM, Collins JL, Belvisi MG.

J Immunol. 2008 Sep 15;181(6):4265-71.

7.

Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.

Colin S, Bourguignon E, Boullay AB, Tousaint JJ, Huet S, Caira F, Staels B, Lestavel S, Lobaccaro JM, Delerive P.

Endocrinology. 2008 Oct;149(10):5128-35. doi: 10.1210/en.2008-0637. Epub 2008 Jun 19.

PMID:
18566121
8.

The nuclear receptor Rev-erbalpha is a liver X receptor (LXR) target gene driving a negative feedback loop on select LXR-induced pathways in human macrophages.

Fontaine C, Rigamonti E, Pourcet B, Duez H, Duhem C, Fruchart JC, Chinetti-Gbaguidi G, Staels B.

Mol Endocrinol. 2008 Aug;22(8):1797-811. doi: 10.1210/me.2007-0439. Epub 2008 May 29.

9.

The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages.

Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, Tontonoz P, Castrillo A.

J Biol Chem. 2006 Oct 27;281(43):32197-206. Epub 2006 Aug 30.

10.

Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.

Blaschke F, Leppanen O, Takata Y, Caglayan E, Liu J, Fishbein MC, Kappert K, Nakayama KI, Collins AR, Fleck E, Hsueh WA, Law RE, Bruemmer D.

Circ Res. 2004 Dec 10;95(12):e110-23. Epub 2004 Nov 11.

PMID:
15539633
11.

Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.

Morales JR, Ballesteros I, Deniz JM, Hurtado O, Vivancos J, Nombela F, Lizasoain I, Castrillo A, Moro MA.

Circulation. 2008 Sep 30;118(14):1450-9. doi: 10.1161/CIRCULATIONAHA.108.782300. Epub 2008 Sep 15.

PMID:
18794391
12.

Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.

Zhang-Gandhi CX, Drew PD.

J Neuroimmunol. 2007 Feb;183(1-2):50-9. Epub 2006 Dec 18.

13.

Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.

Liu QY, Quinet E, Nambi P.

Mol Cell Biochem. 2007 Aug;302(1-2):203-13. Epub 2007 Mar 30.

PMID:
17396233
14.

Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages.

Rébé C, Raveneau M, Chevriaux A, Lakomy D, Sberna AL, Costa A, Bessède G, Athias A, Steinmetz E, Lobaccaro JM, Alves G, Menicacci A, Vachenc S, Solary E, Gambert P, Masson D.

Circ Res. 2009 Aug 14;105(4):393-401. doi: 10.1161/CIRCRESAHA.109.201855. Epub 2009 Jul 23.

PMID:
19628791
15.

Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.

Levin N, Bischoff ED, Daige CL, Thomas D, Vu CT, Heyman RA, Tangirala RK, Schulman IG.

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):135-42. Epub 2004 Nov 11.

PMID:
15539622
16.

Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary.

Matsumoto S, Hashimoto K, Yamada M, Satoh T, Hirato J, Mori M.

Mol Endocrinol. 2009 Jan;23(1):47-60. doi: 10.1210/me.2007-0533. Epub 2008 Nov 26.

17.

Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Díaz M, Gallardo G, de Galarreta CR, Salazar J, Lopez F, Edwards P, Parks J, Andujar M, Tontonoz P, Castrillo A.

Immunity. 2009 Aug 21;31(2):245-58. doi: 10.1016/j.immuni.2009.06.018. Epub 2009 Jul 30.

18.

The conjugated linoleic acid isomer trans-9,trans-11 is a dietary occurring agonist of liver X receptor alpha.

Ecker J, Liebisch G, Patsch W, Schmitz G.

Biochem Biophys Res Commun. 2009 Oct 30;388(4):660-6. doi: 10.1016/j.bbrc.2009.08.048. Epub 2009 Aug 13.

PMID:
19682978
19.

The innate immune response under the control of the LXR pathway.

Valledor AF.

Immunobiology. 2005;210(2-4):127-32. Review.

PMID:
16164019
20.

Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.

Pascual-García M, Rué L, León T, Julve J, Carbó JM, Matalonga J, Auer H, Celada A, Escolà-Gil JC, Steffensen KR, Pérez-Navarro E, Valledor AF.

J Immunol. 2013 Jun 15;190(12):6520-32. doi: 10.4049/jimmunol.1201393. Epub 2013 May 17.

Supplemental Content

Support Center